No Pathogenic Mutations in the Uroplakin III Gene of 25 Patients With Primary Vesicoureteral Reflux
- 1 February 2004
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 171 (2), 931-932
- https://doi.org/10.1097/01.ju.0000094802.50650.3d
Abstract
The uroplakin III (UPIII) knockout mouse provides a good model for human primary vesicoureteral reflux (VUR). Since to our knowledge no causative genes in human VUR have been identified to date, we wondered whether the UPIII gene might be involved in human primary VUR. Therefore, the UPIII gene was sequenced to see if any mutations could be detected in patients with primary VUR. DNA was obtained from 25 patients who were surgically treated for primary VUR. Each patient had a family history positive for VUR. No pathogenic mutations were identified in patient DNA. One missense mutation (Ala154Pro) not reported in the human genome data base was observed. However, because its frequency in the patient and control populations was similar, it was interpreted as a polymorphism. Although mutations in regulatory elements affecting gene function cannot be excluded, the UPIII gene does not seem to have a major role in primary VUR in humans.Keywords
This publication has 6 references indexed in Scilit:
- Screening Siblings for Vesicoureteral RefluxJournal of Urology, 2002
- Angiotensin II Type 2 Receptor Gene is Not Responsible For Familial Vesicoureteral RefluxJournal of Urology, 2002
- Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and RetNature Genetics, 2002
- PALML, a novel paralemmin-related gene mapping on human chromosome 1p21Gene, 2001
- Ablation of Uroplakin III Gene Results in Small Urothelial Plaques, Urothelial Leakage, and Vesicoureteral RefluxThe Journal of cell biology, 2000
- Primary, Nonsyndromic Vesicoureteric Reflux and Its Nephropathy Is Genetically Heterogeneous, with a Locus on Chromosome 1American Journal of Human Genetics, 2000